Answers are grounded in this paper and cite their sources.
Bronchoscopic lung volume reduction has been used in patients with advanced emphysema. We describe the experimental use of an endobronchial valve device to facilitate collapse of the segmental bronchi and effect nonsurgical lung volume reduction. Nine sheep underwent implantation of valve devices into lung segments using flexible bronchoscopy. After 1 week to 6 months, the animals underwent right thoracotomy and gross and histopathologic examination. Of the 40 valve devices placed in segmental bronchi, all but 3 were intact and well seated in the bronchial lumen. Gross collapse was seen distal to 34 devices (34 of 40, 85%). Atelectasis on histopathology was evident distal to 36 devices (36 of 40, 90%); of these, 6 had evidence of pneumonia and 1 had a focal abscess (7 of 36, 19%). Four additional segments had limited foci of inflammation (4 of 36, 11%). Lung volume reduction, as evidenced by atelectasis, can be achieved using bronchoscopically placed valve devices. In this model, device use was associated with pneumonia or abscess in 19% of cases and mild inflammatory changes in 11%. Potential advantages of a bronchoscopic valve device are that it permits bronchial drainage and continued decompression of the distal bronchus. The clinical efficacy of this approach awaits the results of an ongoing clinical trial.
No takes yet. Share an insight, caveat, or question.
Fann et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: